Emerging degrader technologies engaging lysosomal pathways

Y Ding, D Xing, Y Fei, B Lu - Chemical Society Reviews, 2022 - pubs.rsc.org
Targeted protein degradation (TPD) provides unprecedented opportunities for drug
discovery. While the proteolysis-targeting chimera (PROTAC) technology has already …

Application of novel degraders employing autophagy for expediting medicinal research

X Li, Q Liu, X Xie, C Peng, Q Pang, B Liu… - Journal of Medicinal …, 2023 - ACS Publications
Targeted protein degradation (TPD) technology is based on a unique pharmacological
mechanism that has profoundly revolutionized medicinal research by overcoming limitations …

[HTML][HTML] Aging, circadian disruption and neurodegeneration: Interesting interplay

AK Verma, S Singh, SI Rizvi - Experimental Gerontology, 2023 - Elsevier
The circadian system is an intricate molecular network of coordinating circadian clocks that
organize the internal synchrony of the organism in response to the environment. These …

Microglia pyroptosis: a candidate target for neurological diseases treatment

X Wu, T Wan, X Gao, M Fu, Y Duan, X Shen… - Frontiers in …, 2022 - frontiersin.org
In addition to its profound implications in the fight against cancer, pyroptosis have important
role in the regulation of neuronal injury. Microglia are not only central members of the …

Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation

IH Kaltheuner, K Anand, J Moecking, R Düster… - Nature …, 2021 - nature.com
Homeodomain-interacting protein kinases (HIPKs) belong to the CMGC kinase family and
are closely related to dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) …

Lowering mutant huntingtin levels and toxicity: Autophagy-Endolysosome pathways in Huntington's disease

E Valionyte, Y Yang, SL Roberts, J Kelly, B Lu… - Journal of molecular …, 2020 - Elsevier
Huntington's disease (HD) is a monogenetic neurodegenerative disease, which serves as a
model of neurodegeneration with protein aggregation. Autophagy has been suggested to …

Basic and translational aging research in China: present and future

X He, M Song, J Qu, Y Guo, H Cao, R Sun, GH Liu… - Protein & …, 2019 - academic.oup.com
The percentage of elderly people in the world is increasing at an unprecedented pace; so it
is in China, which has the world's largest population and a high ratio of the seniors (aged 60 …

Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes

H Song, H Li, S Guo, Y Pan, Y Fu, Z Zhou, Z Li, X Wen… - Brain, 2018 - academic.oup.com
Abstract See Huang and Gitler (doi: 10.1093/brain/awy112) for a scientific commentary on
this article. Lowering the levels of disease-causing proteins is an attractive treatment …

Investigating the transition of pre-symptomatic to symptomatic huntington's disease status based on omics data

CC Christodoulou, M Zachariou, M Tomazou… - International Journal of …, 2020 - mdpi.com
Huntington's disease is a rare neurodegenerative disease caused by a cytosine–adenine–
guanine (CAG) trinucleotide expansion in the Huntingtin (HTT) gene. Although Huntington's …

Arc regulates transcription of genes for plasticity, excitability and Alzheimer's disease

HW Leung, G Foo, A VanDongen - Biomedicines, 2022 - mdpi.com
The immediate early gene Arc is a master regulator of synaptic function and a critical
determinant of memory consolidation. Here, we show that Arc interacts with dynamic …